Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Instant marijuana use detector using saliva samples in the works

Staff Writer
Staff Writer 7 months ago
Updated 2021/10/23 at 1:20 AM
Share
SHARE

The Breathalyzer revolutionized the detection of alcohol use. Now, the gold standard for detecting marijuana use may have inched closer.

According to a newly published study in Science Translational Medicine, researchers associated with Massachusetts General Hospital developed a test for detecting tetrahydrocannabinol (THC) within saliva samples following marijuana consumption.

The research’s initial experimentation involving 43 marijuana users and 43 drug-free users led to relatively accurate readings of THC in saliva samples from all drug users, according to the findings.

From the study: “To enable on-site THC quantification in minutes, we developed a rapid assay for oral THC analysis called EPOCH (express probe for on-site cannabis inhalation).”

“EPOCH features distinctive sensor design such as a radial membrane and transmission optics, all contained in a compact cartridge.”

“Longitudinal monitoring showed a fast drop in THC concentrations within the first 6 hours of cannabis smoking (half-life, 1.4 hours),” researchers claimed in their findings.

You Might Also Like

Type 2 diabetes may lead to a significant increase in brain aging and cognitive decline

Study finds no structural brain change during mindfulness-based stress training

Study finds diet may be a contributing factor in ADHD symptoms associated in children

New research claims COVID-19 contagion may raise the risk of neurodegenerative disorder

ALS experimental drug NU-9 more efficacious than existing FDA-approved drugs

TAGGED: THC, cannabis, drugs, marijuana
Staff Writer October 22, 2021
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Researchers examine if strenuous exercise may heighten the risk of ALS
Next Article Study suggests Massachusetts gun control legislation led to no reduction in violent crime

Recommended

Clinical

Type 2 diabetes may lead to a significant increase in brain aging and cognitive decline

1 Min Read
Clinical

Study finds no structural brain change during mindfulness-based stress training

1 Min Read
Clinical

Study finds diet may be a contributing factor in ADHD symptoms associated in children

1 Min Read
Clinical

New research claims COVID-19 contagion may raise the risk of neurodegenerative disorder

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?